Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Milestone Pharmaceuticals (MIST) Stock in Focus on Dec. 12, 2025: FDA Decision Countdown, Latest News, Analyst Forecasts, and Key Risks

Milestone Pharmaceuticals (MIST) Stock in Focus on Dec. 12, 2025: FDA Decision Countdown, Latest News, Analyst Forecasts, and Key Risks

Milestone Pharmaceuticals Inc. stock is drawing heightened attention on December 12, 2025 , as investors position ahead of a make-or-break FDA decision for the company's lead program, CARDAMYST™ nasal spray , aimed at treating paroxysmal supraventricular tachycardia . The regulatory catalyst arrives after a volatile year that included an FDA Complete Response Letter earlier in 2025, followed by the FDA's acceptance of Milestone's resubmission and a new target action date set for mid-December.GlobeNewswire+ 2GlobeNewswire+ 2
12 December 2025
·
Centene (CNC) Stock News, Forecasts and Analysis on December 12, 2025: Why Shares Rebounded Near $40 and What Comes Next

Centene (CNC) Stock News, Forecasts and Analysis on December 12, 2025: Why Shares Rebounded Near $40 and What Comes Next

Centene Corporation is ending 2025 with investors focused on a familiar mix of catalysts: Medicaid margin repair, ACA Marketplace volatility, and Washington policy risk. The stock’s latest pop has been driven by a fresh analyst price-target increase, but the broader narrative remains shaped by a dramatic mid-year guidance reset and ongoing uncertainty around Affordable Care Act premium subsidies that are scheduled to expire December 31, 2025. MarketBeat+2Reuters+2
12 December 2025
·
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

December 12, 2025 — Cronos Group Inc. is back in the spotlight after cannabis stocks jumped broadly into early trading on reports that the Trump administration could pursue a major easing of federal marijuana restrictions — specifically, a push to reclassify marijuana from Schedule I to Schedule III .Reuters+ 1
12 December 2025
··
Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025)

Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025)

NEW YORK — December 12, 2025 — Applied Therapeutics, Inc. is in the spotlight after announcing a definitive agreement to be acquired by Cycle Group Holdings Limited, a rare-disease-focused company that operates as Cycle Pharmaceuticals. The headline terms include a small upfront cash payment and a potentially meaningful contingent value right tied to future FDA approvals and sales milestones—setting up a high-volatility, event-driven setup for APLT stock as the market digests what’s “real” value versus what’s optionality. GlobeNewswire
12 December 2025
···
PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express, Inc. — best known as PetMeds and the parent of PetCareRx — is back on traders' radars after a Singapore-based investor publicly disclosed an unsolicited proposal to take the online pet pharmacy private at $4.00 per share in cash . The news sent PETS sharply higher on Thursday, and the market is now trying to answer one question: Is the bid real enough to anchor the stock near $4, or is this a volatility event with meaningful execution risk? GlobeNewswire+ 2DRY+ 2
12 December 2025
··
Costco Stock (COST) Today: Earnings Beat, Membership Momentum, Tariff Lawsuit Headlines, and Fresh Wall Street Forecasts (Dec. 12, 2025)

Costco Stock (COST) Today: Earnings Beat, Membership Momentum, Tariff Lawsuit Headlines, and Fresh Wall Street Forecasts (Dec. 12, 2025)

Costco Wholesale Corporation is back at the center of investor attention on December 12, 2025, after the retailer kicked off fiscal 2026 with a sales and earnings beat, accelerated membership-fee growth, and another quarter of strong comparable sales—even as the stock’s reaction remains measured and headlines swirl around a tariff-related lawsuit. Costco Investor Relations+2Reuters+2
12 December 2025
··
Rezolute (RZLT) Stock Update Dec. 12, 2025: Phase 3 sunRIZE Miss Sparks Selloff, Analysts Reset Targets, and 2026 Catalysts

Rezolute (RZLT) Stock Update Dec. 12, 2025: Phase 3 sunRIZE Miss Sparks Selloff, Analysts Reset Targets, and 2026 Catalysts

Rezolute, Inc. is one of the most closely watched biotech movers heading into the Dec. 12, 2025 session after a pivotal clinical trial miss triggered a historic repricing of the stock. As of the latest available trading update on Friday, December 12, 2025, Rezolute shares are trading around $1.40, down roughly $9.55 versus the prior close—about an 87% one-day collapse that has reset expectations across Wall Street.
12 December 2025
1 … 493 494 495 496 497 … 608
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY IN STAGES

AerCap

NYSE: AER 95 / 100
#2 BUY ON WEAKNESS

Xylem

NYSE: XYL 93 / 100
#3 ACCUMULATE

General Dynamics

NYSE: GD 91 / 100
#4 BUY WITH LIMITS

Visa

NYSE: V 88 / 100
#5 TACTICAL BUY

IDEX

NYSE: IEX 85 / 100
View full portfolio
Editorial model selection. Not personalised advice.